Pediatric antiemetic medications
Pro Research Analysisby 
Searched over 200M research papers
Pediatric Antiemetic Medications: Common Drugs and Indications
Vomiting in children can result from various causes, including acute gastroenteritis, chemotherapy, surgery, and specific syndromes like cannabinoid hyperemesis. The most commonly used antiemetic medications in pediatric care are ondansetron and domperidone, with ondansetron being especially well-studied for acute gastroenteritis and chemotherapy-induced nausea and vomiting (CINV) Romano2019Phillips2016Patel2019+5 MORE.
Ondansetron and 5-HT3 Antagonists for Gastroenteritis and Chemotherapy
Ondansetron, a serotonin 5-HT3 receptor antagonist, is effective in reducing vomiting, the need for intravenous fluids, and hospital admissions in children with acute gastroenteritis. A single oral dose is generally safe and can improve the success of oral rehydration therapy Romano2019Manteuffel2009. For CINV, 5-HT3 antagonists (including ondansetron, granisetron, and palonosetron) are more effective and have fewer side effects than older antiemetics like metoclopramide and phenothiazines Phillips2016Patel2019Navari2017+2 MORE. Granisetron and palonosetron may offer some advantages over ondansetron in certain chemotherapy settings .
Dexamethasone and Combination Therapy
Adding dexamethasone, a corticosteroid, to a 5-HT3 antagonist improves control of vomiting in children receiving chemotherapy. This combination is recommended for patients undergoing highly or moderately emetogenic chemotherapy Phillips2016Patel2019Navari2017+2 MORE. However, the risk-benefit profile of steroids as adjuncts should be considered on a case-by-case basis .
Safety and Adverse Effects of Pediatric Antiemetics
Current clinical guidelines recommend antiemetic agents that are generally safe for children, but patient-specific risk factors, such as the potential for cardiac arrhythmia, should be evaluated before prescribing . Ondansetron is considered safe for single-dose use in gastroenteritis, while older drugs like promethazine, prochlorperazine, and metoclopramide are associated with more frequent and potentially dangerous side effects . Long-term safety data for newer agents are still needed .
Special Considerations: Postoperative and Syndrome-Specific Antiemetic Use
For postoperative nausea and vomiting (PONV), a multimodal approach is recommended, often combining dexamethasone and a 5-HT3 antagonist like ondansetron. This strategy is effective in reducing PONV and related complications in children at risk Kovac2020Wang2021. In cases of cannabinoid hyperemesis syndrome (CHS), nontraditional antiemetics such as benzodiazepines and haloperidol may be more effective than traditional agents, though abstinence from cannabis remains the most effective intervention .
Gaps in Evidence and Future Directions
While 5-HT3 antagonists and combination therapies are effective for acute vomiting, there is limited evidence for the prevention of delayed or anticipatory nausea and vomiting in children. More research is needed to determine optimal dosing, long-term safety, and the best strategies for specific pediatric populations Phillips2016Patel2019Navari2017+1 MORE.
Conclusion
Ondansetron and other 5-HT3 antagonists are the mainstay of pediatric antiemetic therapy for acute gastroenteritis and chemotherapy-induced nausea and vomiting, with dexamethasone often used as an adjunct in chemotherapy settings. These agents are generally safe, but careful patient assessment is important. Older antiemetics are less favored due to safety concerns. Multimodal and combination therapies are increasingly used for postoperative and syndrome-specific vomiting. Ongoing research is needed to address gaps in evidence, especially for delayed and anticipatory nausea and vomiting in children.
Sources and full results
Most relevant research papers on this topic